Silo Pharma, Inc. (SILO) › Cash & EquivalentsSilo Pharma, Inc. (SILO) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2010: $47.5K2011: $1.8K2012: $2792013: $2.01M2016: $579.2K2017: $294.6K2018: $336.7K2019: $111.8K2020: $1.13M2021: $9.84M2022: $11.37M2023: $3.52M2024: $3.91M2025: $4.75M$4.75M2010Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$4.75M+21.6%2024$3.91M+10.8%2023$3.52M-69.0%2022$11.37M+15.6%2021$9.84M+771.8%2020$1.13M+909.7%2019$111.8K-66.8%2018$336.7K+14.3%2017$294.6K-49.1%2016$579.2K—2013$2.01M+720552.3%2012$279-84.1%2011$1.8K-96.3%2010$47.5K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share